Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Lel H who wrote (719)	6/16/1999 3:35:00 AM
From: Rocketman	Read Replies (2) \| Respond to of 1139

ICOS is very overvalued relative to other biotechs. It just doesn't seem to me to justify a $1.5B market cap. While it is a good company, it just isn't THAT good. I think there is a lot of money that follows it because brotha Bill G. is invested in it, and George R. had a big hit with AMGEN. Also, this is a biotech that was founded with a golden spoon to the tune of $30M first round money, they have never learned how to run lean and scared. So, they tell a good story, spend lots of money and still have not had any success getting anything to market yet. Will it be a long term success - probably. But, can they sustain this market cap in the short term - I doubt it. I shorted ICOS in the VDXXX Stock Model on March 29th at $35 3/8 and still feel that it is overvalued. Message 8595808 Rman